TriVascular
Medical device company focused on development, clinical evaluation and commercialization of endovascular therapies for vascular disease. Emphasizes randomized clinical trials and long-term surveillance, device engineering for challenging anatomies (adaptive sealing and low-profile delivery), immersive procedural simulation, investigator-initiated research collaboration, and reimbursement support for novel therapies.
Industries
Nr. of Employees
large (251-1000)
TriVascular
Patents
Durable stent graft with tapered struts and stable delivery methods and devices
US-12268621-B2
View Details
Durable stent graft with tapered struts and stable delivery methods and devices
US-12268621-B2
View DetailsProducts
Abdominal endovascular stent graft with conformable sealing mechanism
Endovascular abdominal stent graft engineered to create a patient-specific seal via a conformable sealing mechanism, intended for infrarenal aneurysm repair in anatomies with short proximal necks and delivered via a low-profile vascular introducer system.
Bifurcated unibody endovascular stent graft
An anatomically fixated bifurcated unibody stent graft design that preserves native bifurcation and separates fixation from the sealing zone for abdominal aortic aneurysm repair.
Percutaneous transmural arterial bypass system
A percutaneous bypass therapy that creates an artery-vein-artery conduit using a crossing device and dedicated stent grafts routed through the femoral vein to re-establish flow across long femoropopliteal lesions.
Abdominal endovascular stent graft with conformable sealing mechanism
Endovascular abdominal stent graft engineered to create a patient-specific seal via a conformable sealing mechanism, intended for infrarenal aneurysm repair in anatomies with short proximal necks and delivered via a low-profile vascular introducer system.
Bifurcated unibody endovascular stent graft
An anatomically fixated bifurcated unibody stent graft design that preserves native bifurcation and separates fixation from the sealing zone for abdominal aortic aneurysm repair.
Percutaneous transmural arterial bypass system
A percutaneous bypass therapy that creates an artery-vein-artery conduit using a crossing device and dedicated stent grafts routed through the femoral vein to re-establish flow across long femoropopliteal lesions.
Services
Immersive VR training and multi-user simulation for endovascular procedures with remote access, repetitive practice and performance data capture.
Provision of facility and physician coding guides, payer-facing resources and dedicated reimbursement support to assist hospitals and providers with payment pathways.
Evaluation and administrative support for external investigators including application review, feedback, contracting and payment milestone management for approved studies.
Immersive VR training and multi-user simulation for endovascular procedures with remote access, repetitive practice and performance data capture.
Provision of facility and physician coding guides, payer-facing resources and dedicated reimbursement support to assist hospitals and providers with payment pathways.
Evaluation and administrative support for external investigators including application review, feedback, contracting and payment milestone management for approved studies.
Expertise Areas
- Clinical trial management and outcomes analysis
- Real-world evidence and registry-based surveillance
- Endovascular device engineering for complex anatomies
- Peripheral vascular therapeutics (AAA and PAD interventions)
Key Technologies
- Endovascular stent graft systems
- Conformable/adaptive sealing mechanisms
- Low-profile vascular delivery systems (≤13F inner diameter)
- PTFE-based graft materials
News & Updates
Company announcement regarding appointment of a new board member with medtech executive experience.
Company update reporting a clinical adoption milestone for the percutaneous bypass therapy.
Summary of NTAP and TPT payment support for the percutaneous bypass system and associated reimbursement resources.
Regulatory designation and associated NTAP/TPT payment pathways for the percutaneous transmural arterial bypass system.
Initiated randomized controlled trials and published multi-year outcome analyses, with pooled and registry-linked surveillance studies evaluating long-term device performance.
Public notice of regulatory approval for the percutaneous bypass system for treatment of complex femoropopliteal lesions.
Company announcement regarding appointment of a new board member with medtech executive experience.
Company update reporting a clinical adoption milestone for the percutaneous bypass therapy.
Summary of NTAP and TPT payment support for the percutaneous bypass system and associated reimbursement resources.
Regulatory designation and associated NTAP/TPT payment pathways for the percutaneous transmural arterial bypass system.
Initiated randomized controlled trials and published multi-year outcome analyses, with pooled and registry-linked surveillance studies evaluating long-term device performance.
Public notice of regulatory approval for the percutaneous bypass system for treatment of complex femoropopliteal lesions.